Live Attenuated Herpes Zoster Vaccine Market was valued at USD 2.8 Billion in 2022 and is projected to reach USD 5.3 Billion by 2030, growing at a CAGR of 8.7% from 2024 to 2030.
The global market for live attenuated herpes zoster vaccines is experiencing significant growth, driven by an aging population and increasing awareness of shingles prevention. This article delves into the current market dynamics, key players, and future trends shaping the industry.
Herpes zoster, commonly known as shingles, is a reactivation of the varicella-zoster virus—the same virus responsible for chickenpox. It manifests as a painful rash and can lead to complications such as postherpetic neuralgia. Live attenuated vaccines, like Zostavax, use a weakened form of the virus to stimulate an immune response, thereby reducing the risk of developing shingles.
As of 2023, the global zoster vaccine market was valued at USD 4.2 billion and is projected to reach USD 9.1 billion by 2033, growing at a compound annual growth rate (CAGR) of 8.1% during the forecast period. This growth is attributed to improved healthcare policies and the rising incidence of shingles among individuals aged 60 and above.
Merck & Co., Inc.
GSK plc
Pfizer Inc.
Jiangsu Recbio Technology Co., Ltd
SK Chemicals
These companies are actively involved in research and development to enhance vaccine efficacy and expand their market presence.
North America dominated the market in 2023, accounting for 42.3% of the global revenue. This is due to the high incidence of chickenpox and shingles, coupled with robust healthcare infrastructure.
Despite the benefits, the effectiveness of live attenuated vaccines like Zostavax has been observed to wane over time. Studies indicate that vaccine effectiveness decreases from 67% in the first year to 15% after ten years. This presents opportunities for the development of more durable vaccines and booster strategies.
The market is witnessing a shift towards recombinant vaccines, such as Shingrix, which offer longer-lasting protection. Additionally, ongoing research into mRNA vaccine candidates by companies like Pfizer and BioNTech signifies a promising avenue for innovation in shingles prevention.
The live attenuated herpes zoster vaccine market is poised for substantial growth, driven by demographic trends and advancements in vaccine technology. Continuous research and development, along with strategic collaborations, will be crucial in addressing existing challenges and meeting the global demand for effective shingles prevention.
Download Full PDF Sample Copy of Global Live Attenuated Herpes Zoster Vaccine Report @ https://www.verifiedmarketreports.com/download-sample/?rid=448634&utm_source=Google_Site_Feb&utm_medium=231
Merck & Co.
SK Bioscience
GlaxoSmithKline (GSK)
Beike Bio
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=448634&utm_source=Google_Site_Feb&utm_medium=231
Growing demand for below applications around the world has had a direct impact on the growth of the Global Live Attenuated Herpes Zoster Vaccine Market
Hospital
Clinic
Epidemic Prevention Center
Others
Based on Types the Market is categorized into Below types that held the largest Live Attenuated Herpes Zoster Vaccine market share In 2023.
40-50 Years Old
50-60 Years Old
60-70 Years Old
>70 Years Old
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/live-attenuated-herpes-zoster-vaccine-market/
1. Introduction of the Global Live Attenuated Herpes Zoster Vaccine Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Live Attenuated Herpes Zoster Vaccine Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Live Attenuated Herpes Zoster Vaccine Market, By Type
6. Global Live Attenuated Herpes Zoster Vaccine Market, By Application
7. Global Live Attenuated Herpes Zoster Vaccine Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Live Attenuated Herpes Zoster Vaccine Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/